Jefferies Assumes Nautilus Biotechnology at Hold, Lowers Price Target of $3
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Tycho Peterson has assumed coverage of Nautilus Biotechnology (NASDAQ:NAUT) with a Hold rating and has lowered the price target to $3.
June 03, 2024 | 6:16 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Jefferies analyst Tycho Peterson has assumed coverage of Nautilus Biotechnology with a Hold rating and has lowered the price target to $3.
The Hold rating suggests a neutral stance, indicating that the stock is expected to perform in line with the market. The lowered price target to $3 may reflect a more cautious outlook on the company's future performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100